Skip to main content
SpringerLink
Log in

Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

Obesity, type 2 diabetes mellitus (T2DM), and obstructive sleep apnea (OSA) are associated with chronic low-grade inflammation. Iron metabolism is linked with insulin-resistant states and with OSA in adults. The association of body iron status with T2DM in children remains undefined. We aimed to evaluate plasma interleukin-6 (IL-6), hepcidin, and soluble transferrin receptor (sTfR) levels in obese patients with T2DM or impaired glucose tolerance (IGT) and in those without, and the contribution of OSA to their levels.

Methods

In this cross-sectional study, obese children and adolescents with and without T2DM/IGT underwent overnight polysomnography. Fasting plasma concentrations of IL-6, hepcidin, and sTfR were measured and evaluated according to glycemic status (T2DM/IGT and normal glucose tolerance) and the presence of OSA.

Results

Ten patients with T2DM (age 15.9 ± 3.6 years), 8 with IGT (age 13.1 ± 2.5 years) and 20 subjects with normal glucose tolerance matched for body mass index standard deviation score (age 12.6 ± 3.3 years) were studied. Sleep measures or IL-6, hepcidin, and sTfR levels were not significantly different between the group with T2DM/IGT vs. the control group. No significant differences were found in hepcidin or sTfR levels between patients with OSA and those without. However, patients with OSA showed higher plasma IL-6 values compared with those without (4.56 ± 2.92 vs. 2.83 ± 1.54 pg/ml, P = 0.025), and the highest values were evident in patients affected by both T2DM/IGT and OSA.

Conclusions

Higher IL-6 levels were associated with both glycemic status and OSA. No differences in body iron regulator levels were found in obese patients with T2DM/IGT compared to those without or in those with OSA compared to those without. Further longitudinal studies in larger population samples are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Vivian EM (2006) Type 2 diabetes in children and adolescents-the next epidemic? Curr Med Res Opin 22:297–306

    Article  PubMed  Google Scholar 

  2. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G (1999) Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 159:1527–1532

    Article  PubMed  CAS  Google Scholar 

  3. Singer K, Eng DS, Lumeng CN, Gebremariam A, Lee JM (2014) The relationship between body fat mass percentiles and inflammation in children. Obesity 22(5):1332–1336

    Article  PubMed  CAS  Google Scholar 

  4. Gozal D (2009) Sleep, sleep disorders and inflammation in children. Sleep Med 10(Suppl 1):S12–S16

    Article  PubMed  Google Scholar 

  5. Hanley AJ, Festa A, D’Agostino RB Jr et al (2004) Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53(7):1773–1781

    Article  PubMed  CAS  Google Scholar 

  6. Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R (2005) Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 31(1):55–62

    Article  PubMed  CAS  Google Scholar 

  7. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9(7):414–417

    Article  PubMed  CAS  Google Scholar 

  8. Cardellini M, Andreozzi F, Laratta E et al (2007) Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev 23(2):141–145

    Article  PubMed  CAS  Google Scholar 

  9. Tauman R, O’Brien LM, Gozal D (2007) Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath 11(2):77–84

    Article  PubMed  Google Scholar 

  10. Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810

    Article  PubMed  CAS  Google Scholar 

  11. Hamza RT, Hamed AI, Kharshoum RR (2013) Iron homeostasis and serum hepcidin-25 levels in obese children and adolescents: relation to body mass index. Horm Res Paediatr 80(1):11–17

    Article  PubMed  CAS  Google Scholar 

  12. Martinelli N, Traglia M, Campostrini N et al (2012) Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. PLoS One 7(10):e48250

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Freixenet N, Remacha A, Berlanga E et al (2009) Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia. Clin Chim Acta 400(1–2):111–116

    Article  PubMed  CAS  Google Scholar 

  14. Aeberli I, Hurrell RF, Zimmermann MB (2009) Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int J Obes 33(10):1111–1117

    Article  CAS  Google Scholar 

  15. Jiang F, Sun ZZ, Tang YT, Xu C, Jiao XY (2011) Hepcidin expression and iron parameters change in type 2 diabetic patients. Diabetes Res Clin Pract 93(1):43–48

    Article  PubMed  CAS  Google Scholar 

  16. Andrews M, Soto N, Arredondo-Olguín M (2015) Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Nutrition 31(1):51–57

    Article  PubMed  CAS  Google Scholar 

  17. Suárez-Ortegón MF, Moreno M, Arbeláez A et al (2015) Circulating hepcidin in type 2 diabetes: a multivariate analysis and double-blind evaluation of metformin effects. Mol Nutr Food Res 59(12):2460–2470

    Article  PubMed  CAS  Google Scholar 

  18. Rajpathak SN, Wylie-Rosett J, Gunter MJ, Diabetes Prevention Program (DPP) Research Group et al (2009) Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab 11(5):472–479

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Liu Y, Yu Z, Hua D, Chen Y, Zheng S, Wang L (2015) Association of serum hepcidin levels with the presence and severity of obstructive sleep apnea syndrome. Med Sci Monit 21:27–31

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Shalitin S, Tauman R, Meyerovitch J, Sivan Y (2014) Are frequency and severity of sleep-disordered breathing in obese children and youth with and without type 2 diabetes mellitus different? Acta Diabetol 51(5):757–764

    Article  PubMed  CAS  Google Scholar 

  21. Iber C, Ancoli-Israel S, Chesson A, Quan SF, For the American Academy of Sleep Medicine (2007) Rules, terminology and technical specifications. The AASM Manual for the Scoring of Sleep and Associated Events, 1st edn. American Academy of Sleep Medicine, Westchester

  22. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334

    Article  PubMed  CAS  Google Scholar 

  23. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB (2009) The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 1790:671–681

    Article  PubMed  CAS  Google Scholar 

  24. Fernandez-Real JM, Lopez-Bermejo A, Ricart W (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51:2348–2354

    Article  PubMed  CAS  Google Scholar 

  25. Abraham D, Rogers J, Gault P, Kushner JP, McClain DA (2006) Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis. Diabetologia 49:2546–2551

    Article  PubMed  CAS  Google Scholar 

  26. Lou DQ, Lesbordes JC, Nicolas G et al (2005) Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology 41:1056–1064

    Article  PubMed  CAS  Google Scholar 

  27. Coimbra S, Catarino C, Santos-Silva A (2013) The role of adipocytes in the modulation of iron metabolism in obesity. Obes Rev 14:771–779

    Article  PubMed  CAS  Google Scholar 

  28. Fernández-Real JM, Moreno JM, López-Bermejo A, Chico B, Vendrell J, Ricart W (2007) Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity. Diabetes Care 30(3):604–608

    Article  PubMed  CAS  Google Scholar 

  29. Fernández-Cao JC, Arija V, Aranda N et al (2017) Soluble transferrin receptor and risk of type 2 diabetes in the obese and nonobese. Eur J Clin Invest 47(3):221–230

    Article  PubMed  CAS  Google Scholar 

  30. Hernández C, Lecube A, Carrera A, Simó R (2005) Soluble transferrin receptors and ferritin in type 2 diabetic patients. Diabet Med 22(1):97–101

    Article  PubMed  CAS  Google Scholar 

  31. Montonen J, Boeing H, Steffen A et al (2012) Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia 55(10):2613–2621

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Guo X, Zhou D, An P et al (2013) Associations between serum hepcidin, ferritin and Hb concentrations and type 2 diabetes risks in a Han Chinese population. Br J Nutr 110(12):2180–2185

    Article  PubMed  CAS  Google Scholar 

  33. Gileles-Hillel A, Alonso-Álvarez ML, Kheirandish-Gozal L et al (2014) Inflammatory markers and obstructive sleep apnea in obese children: the NANOS study. Mediat Inflamm. https://doi.org/10.1155/2014/605280

    Article  Google Scholar 

  34. Gaffney-Stomberg E, McClung JP (2012) Inflammation and diminished iron status: mechanisms and functional outcomes. Curr Opin Clin Nutr Metab Care 15:605–613

    Article  PubMed  CAS  Google Scholar 

  35. Park KH, Sawada T, Kosuge T et al (2012) Surgical inflammation induces hepcidin production after abdominal surgery. World J Surg 36:800–806

    Article  PubMed  Google Scholar 

  36. Tauman R, Lavie L, Greenfeld M, Sivan Y (2014) Oxidative stress in children with obstructive sleep apnea syndrome. J Clin Sleep Med 10(6):677–678

    PubMed  PubMed Central  Google Scholar 

  37. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Ruth Shtern for the ELISA assays performed in the Hematology laboratory of Tel Aviv Medical Center.

Author information

Authors and Affiliations

  1. The Jesse Z. and Lea Shafer, Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel, 14 Kaplan St., 49202, Petach Tikva, Israel

    S. Shalitin

  2. The Hematology Institute, Tel Aviv Medical Center, Tel Aviv, Israel

    V. Deutsch

  3. Pediatric Sleep Laboratory, Dana Children’s Hospital, Tel Aviv Medical Center, Tel Aviv, Israel

    R. Tauman

  4. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    S. Shalitin, V. Deutsch & R. Tauman

Authors
  1. S. Shalitin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Deutsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Tauman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SS was responsible for acquisition of data analysis, interpretation of data; drafting the article and revising it critically for important intellectual content. VD was responsible for performance of the laboratory studies, and revising the article critically for important intellectual content. RT has substantial contributions to conception and design, analysis and interpretation of data; and revising it critically for important intellectual content.

Corresponding author

Correspondence to S. Shalitin.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee of the Belinson-Schneider hospital and with the Helsinki declaration of 1975, and its later amendments or comparable ethical standards.

Informed consent

All eligible patients or their parents gave their written informed consent to participate in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shalitin, S., Deutsch, V. & Tauman, R. Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea. J Endocrinol Invest 41, 969–975 (2018). https://doi.org/10.1007/s40618-017-0823-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0823-7

Keywords

Search

Navigation